These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Fluoroquinolones--a new and important group of antimicrobial agents]. Sander J Tidsskr Nor Laegeforen; 1992 Jan; 112(3):346-9. PubMed ID: 1553674 [TBL] [Abstract][Full Text] [Related]
47. The use of systemic fluoroquinolones. Committee on Infectious Diseases Pediatrics; 2006 Sep; 118(3):1287-92. PubMed ID: 16951028 [TBL] [Abstract][Full Text] [Related]
48. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
49. [Fluoroquinolones, 10 years later]. de la Blanchardière A; Carbon C Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228 [TBL] [Abstract][Full Text] [Related]
50. What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections? Momméja-Marin H; Carbon C Drugs; 1999 Jun; 57(6):851-3. PubMed ID: 10400400 [TBL] [Abstract][Full Text] [Related]
51. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Martin SJ; Jung R; Garvin CG Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723 [TBL] [Abstract][Full Text] [Related]
52. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Croom KF; Goa KL Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657 [TBL] [Abstract][Full Text] [Related]
53. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492. Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651 [TBL] [Abstract][Full Text] [Related]
54. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test. Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053 [TBL] [Abstract][Full Text] [Related]
59. Ciprofloxacin in multi-resistant infections in childhood: an audit. Khan DM; Bhutta ZA J Pak Med Assoc; 1995 Jun; 45(6):147-50. PubMed ID: 7474287 [TBL] [Abstract][Full Text] [Related]
60. Clinical perspectives on new antimicrobials: focus on fluoroquinolones. Talan DA Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]